Vives Fund (investor - Venture Capital)
See something wrong or missing? Let us know
Offices:Bruxelles
Vives is an interregional seed and early stage technology multi-sector fund from Belgium and dedicated to investing in technology-based companies.
- Sopartec, the managing company of Vives II, is the technology transfer company of UCL.
- in 2024, Vives announced a second close with a €38 million additional capital to a fund dedicated to high-tech early-stage life science startups from Europe.
Average round investment:28.41M USD
Average number per year:2.0
Distribution:
2025 (1)2024 (4)2021 (2)2020 (2)2017 (1)
Mostly invests in:
Belgium (7)
Biotech (8)

See the entire list
Showing 3 of 10 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Vives Fund mostly invests with:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Vives Fund
Name | Criteria | |
---|---|---|
![]() |
blisce/
100%
|
|
![]() |
Creadev
100%
|
|
![]() |
KPN Ventures
100%
|
|
![]() |
BBVA
100%
|
|
![]() |
Korys
100%
|
|
![]() |
Seroba Life Sciences
100%
|
|
![]() |
Amundi Asset Management
100%
|
|
![]() |
Allianz
100%
|
|
![]() |
Belfius Bank
100%
|
|
![]() |
EDF Group
100%
|
|